Difference between revisions of "IDRPublicationList"
From Clinfowiki
(→True positive) |
|||
| Line 4: | Line 4: | ||
* ROSIGLITAZONE and claims study - Nationwide, observational, retrospective, inception cohort of 227,571 Medicare beneficiaries aged 65 years or older (mean age, 74.4 years) who initiated treatment with rosiglitazone or pioglitazone through a Medicare Part D prescription drug plan from July 2006-June 2009 and who underwent follow-up for up to 3 years after thiazolidinedione initiation. | * ROSIGLITAZONE and claims study - Nationwide, observational, retrospective, inception cohort of 227,571 Medicare beneficiaries aged 65 years or older (mean age, 74.4 years) who initiated treatment with rosiglitazone or pioglitazone through a Medicare Part D prescription drug plan from July 2006-June 2009 and who underwent follow-up for up to 3 years after thiazolidinedione initiation. | ||
** Graham DJ et al. Risk of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare patients treated with rosiglitazone or pioglitazone. JAMA doi:10.1001/jama.2010.920 http://www.ncbi.nlm.nih.gov/pubmed/20584880 | ** Graham DJ et al. Risk of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare patients treated with rosiglitazone or pioglitazone. JAMA doi:10.1001/jama.2010.920 http://www.ncbi.nlm.nih.gov/pubmed/20584880 | ||
| − | ** http://en.wikipedia.org/wiki/Rosiglitazone | + | **** http://en.wikipedia.org/wiki/Rosiglitazone |
| + | |||
* CIMETIDINE and drug repurposing. Database finding lead to a mouse model (confirmed effect) (clinical trial started [documentation missing] | * CIMETIDINE and drug repurposing. Database finding lead to a mouse model (confirmed effect) (clinical trial started [documentation missing] | ||
Revision as of 20:16, 5 April 2013
List of publications that report use of an IDR
True positive
- ROSIGLITAZONE and claims study - Nationwide, observational, retrospective, inception cohort of 227,571 Medicare beneficiaries aged 65 years or older (mean age, 74.4 years) who initiated treatment with rosiglitazone or pioglitazone through a Medicare Part D prescription drug plan from July 2006-June 2009 and who underwent follow-up for up to 3 years after thiazolidinedione initiation.
- Graham DJ et al. Risk of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare patients treated with rosiglitazone or pioglitazone. JAMA doi:10.1001/jama.2010.920 http://www.ncbi.nlm.nih.gov/pubmed/20584880
- CIMETIDINE and drug repurposing. Database finding lead to a mouse model (confirmed effect) (clinical trial started [documentation missing]
- cimetidine and lung cancer http://www.ncbi.nlm.nih.gov/pubmed/21849665
